These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19201411)

  • 1. Small dense LDL-cholesterol determined by a simple precipitation assay for screening familial combined hyperlipidemia.
    Hirano T; Nohtomi K; Sato Y; Kamata K; Ito Y
    Atherosclerosis; 2009 Aug; 205(2):603-7. PubMed ID: 19201411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.
    Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small dense low-density lipoprotein in familial combined hyperlipidemia: Independent of metabolic syndrome and related to history of cardiovascular events.
    Pauciullo P; Gentile M; Marotta G; Baiano A; Ubaldi S; Jossa F; Iannuzzo G; Faccenda F; Panico S; Rubba P
    Atherosclerosis; 2009 Mar; 203(1):320-4. PubMed ID: 18760784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained?
    Brouwers MC; de Graaf J; van Greevenbroek MM; Georgieva AM; van der Kallen CJ; Ter Avest E; Stehouwer CD; Stalenhoef AF; de Bruin TW
    Clin Sci (Lond); 2008 Mar; 114(5):393-401. PubMed ID: 17953518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative assessment of LDL-C and VLDL-C estimation in familial combined hyperlipidemia using Sampson's, Martin's and Friedewald's equations.
    Vargas-Vázquez A; Bello-Chavolla OY; Antonio-Villa NE; Mehta R; Cruz-Bautista I; Aguilar-Salinas CA
    Lipids Health Dis; 2021 May; 20(1):46. PubMed ID: 33952259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of LDL-C calculated with Martin's formula compared to the Friedewald equation in familial combined hyperlipidemia.
    Mehta R; Reyes-Rodríguez E; Yaxmehen Bello-Chavolla O; Guerrero-Díaz AC; Vargas-Vázquez A; Cruz-Bautista I; A Aguilar-Salinas C
    Atherosclerosis; 2018 Oct; 277():204-210. PubMed ID: 29970255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial combined hyperlipidemia (FCHL) in children: the significance of early development of hyperapoB lipoproteinemia, obesity and aging.
    Kuromori Y; Okada T; Iwata F; Hara M; Noto N; Harada K
    J Atheroscler Thromb; 2002; 9(6):314-20. PubMed ID: 12560593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia without changing LDL subclass pattern.
    Franceschini G; Cassinotti M; Vecchio G; Gianfranceschi G; Pazzucconi F; Murakami T; Sirtori M; D'Acquarica AL; Sirtori CR
    Arterioscler Thromb; 1994 Oct; 14(10):1569-75. PubMed ID: 7918306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma triglycerides and LDL cholesterol are related in a parabolic fashion in the general population and patients with Type 2 diabetes mellitus: long-term follow-up results from the Hoorn study.
    Brouwers MC; Dekker JM; van Greevenbroek MM; van der Kallen CJ; Heine RJ; de Bruin TW; Stehouwer CD
    Diabet Med; 2008 Sep; 25(9):1121-4. PubMed ID: 19183319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia.
    Rauh G; Schuster H; Müller B; Schewe S; Keller C; Wolfram G; Zöllner N
    Atherosclerosis; 1990 Jul; 83(1):81-7. PubMed ID: 1975179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased intima-media thickness in familial combined hyperlipidemia associated with apolipoprotein B.
    Keulen ET; Kruijshoop M; Schaper NC; Hoeks AP; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):283-8. PubMed ID: 11834529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study.
    Veerkamp MJ; de Graaf J; Hendriks JC; Demacker PN; Stalenhoef AF
    Circulation; 2004 Jun; 109(24):2980-5. PubMed ID: 15184285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cholestyramine in the treatment of children with familial combined hyperlipidemia.
    Liacouras CA; Coates PM; Gallagher PR; Cortner JA
    J Pediatr; 1993 Mar; 122(3):477-82. PubMed ID: 8441109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemia.
    Austin MA; Horowitz H; Wijsman E; Krauss RM; Brunzell J
    Atherosclerosis; 1992 Jan; 92(1):67-77. PubMed ID: 1575822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin.
    Sirtori CR; Calabresi L; Pisciotta L; Cattin L; Pauciullo P; Montagnani M; Manzato E; Bittolo Bon G; Fellin R
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):47-55. PubMed ID: 15871851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins.
    Vakkilainen J; Jauhiainen M; Ylitalo K; Nuotio IO; Viikari JS; Ehnholm C; Taskinen MR
    J Lipid Res; 2002 Apr; 43(4):598-603. PubMed ID: 11907142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombotic markers in familial combined hyperlipidemia: evidence of endothelial cell activation and relation to metabolic syndrome.
    Georgieva AM; Cate HT; Keulen ET; van Oerle R; Govers-Riemslag JW; Hamulyák K; van der Kallen CJ; Van Greevenbroek MM; De Bruin TW
    Atherosclerosis; 2004 Aug; 175(2):345-51. PubMed ID: 15262191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of evidence for linkage between low-density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia.
    Austin MA; Wijsman E; Guo SW; Krauss RM; Brunzell JD; Deeb S
    Genet Epidemiol; 1991; 8(5):287-97. PubMed ID: 1761202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia.
    Austin MA; Brunzell JD; Fitch WL; Krauss RM
    Arteriosclerosis; 1990; 10(4):520-30. PubMed ID: 2369363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.